Skip to content
Open access

Drug target prediction from perturbation transcriptomics via a biological function-guided hypergraph siamese network

Aug 2026 · Bioinform. · Vol 42 · 0 citations · 29 references
Medicine Computer Science

TL;DR

BioHSNet, a biological function-guided hypergraph siamese network for inferring drug-target interactions from perturbation transcriptomics, utilizes hyperedge representations of functionally grouped gene expression to capture higher-order functional relationships, and integrates compound structural information into the model to bridge chemical structure and functional response.

Abstract

Abstract Motivation Understanding how small molecules modulate cellular states remains a critical challenge in drug discovery. The advent of perturbation transcriptomics offers new avenues for elucidating drug-target interactions by capturing cellular transcriptional responses to perturbations. Results In this study, we propose BioHSNet, a biological function-guided hypergraph siamese network for inferring drug-target interactions from perturbation transcriptomics. BioHSNet utilizes hyperedge representations of functionally grouped gene expression to capture higher-order functional relationships, and integrates compound structural information into the model to bridge chemical structure and functional response. Experimental results demonstrate that BioHSNet outperforms other transcriptome-based methods on the Broad Institute’s L1000 datasets, particularly in cold start scenarios. The case study further demonstrates its practical utility for target prediction and drug screening. Availability and Implementation The source code is available at https://github.com/Zxinyizhang/BioHSNet.

Read PDF

Similar papers

Sep 2026

GraphPert: A graph autoencoder framework for network-based drug repurposing using transcriptional signatures-A case study on melanoma.

GraphPert demonstrates that propagating transcriptional signatures through a pre-trained GAE extends the reach of virtual screening beyond direct transcriptional similarity, enabling the discovery of mechanistically diverse compounds that recapitulate the network-level effects of a therapeutic reference perturbation.

G. A. Conti, J. L. Gómez Chávez, Ernesto Rafael Perez et al. · 0 citations
Aug 2026

IHLO-DTI: Drug-Target Interaction Prediction Based on Improved Hypergraph Neural Network and Laplacian Matrix Optimization

IHLO-DTI, a novel prediction model based on an improved hypergraph neural network and Laplacian matrix optimization, can effectively capture high-order many-to-many interactions between drugs and targets, improving prediction accuracy and robustness.

Guolongwei Dai, Tao Luo, Dan-Dan Li et al. · 0 citations
Aug 2026

Predicting circRNA-Drug Sensitivity Using Integrated Hybrid Graph and Molecular Features.

Case studies further validated predicted circRNA-drug associations, including cisplatin, enzalutamide, and sorafenib, against published experimental findings, demonstrating HMCDSP's capacity to reveal clinically relevant biomarkers and inform personalized therapeutic strategies.

Yong-Tian Wang, Wen-Kai Shen, Jiahao Li et al. · 0 citations
Sep 2026

MoaNet: Learning Protein–Ligand Mechanism of Action from Transcriptional Profiles and Sequence Information

Understanding the functional interactions between molecules and their targets is critical in drug discovery. While current computational approaches achieve high accuracy in predicting drug–target interactions, they often fail to capture the functional consequences of these interactions, such as agonistic or antagonis...

Yue-Hui Qian, Xin-Pei Sun, Li-Sheng Zhang et al. · 0 citations
Open access Aug 2026

Chemi-Proteome Language Attention Network Empowers Fragment-Based Ligand Interactome and Binding Sites Discovery with Evidence

By learning directly from cellular chemoproteomics, C-PLANK moves beyond isolated interaction prediction toward cellular interaction-state modelling, establishing a computational foundation for future digital-twin frameworks in drug discovery.

Bing-Song Liao, Ji-Xiao He, Mingzhu Zhao et al. · 0 citations
Open access Aug 2026

A mechanism-annotated benchmark reveals limited fidelity to drug-response signatures in single-cell perturbation models

Single-cell drug perturbation models are increasingly used to predict how compounds remodel cellular states, but they are still largely assessed by expression reconstruction. Whether high expression similarity reflects preservation of drug-response signatures remains unclear. Here we present scDrugPerturb-Bench, a mech...

Le-Hang Li, Shaoming Duan, Xin-Xiang Zha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.